This inventor holds 2 USPTO granted patents. Top assignee: Aurobindo Pharma Limited. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Kishore Karumanchi: Innovator in Pharmaceutical Processes
Introduction
Kishore Karumanchi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. With a total of 2 patents to his name, his work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Kishore's latest patents include a process for the preparation of DL-proline co-crystal of Dapagliflozin. This invention relates to a method for creating Dapagliflozin DL-Proline co-crystal and its application in the preparation and purification of Dapagliflozin. Additionally, he has developed a process for the preparation of Raltegravir, which involves creating a crystalline anhydrous compound and its use in the preparation of Raltegravir or its pharmaceutically acceptable salt.
Career Highlights
Kishore Karumanchi is currently associated with Aurobindo Pharma Limited, where he applies his expertise in pharmaceutical innovations. His work focuses on enhancing drug formulations and improving the efficiency of pharmaceutical processes.
Collaborations
Kishore has collaborated with several professionals in his field, including Sivakumaran Meenakshisunderam and Jagan Mohan Reddy Sanapureddy. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kishore Karumanchi stands out as an influential inventor in the pharmaceutical sector, with his innovative processes paving the way for advancements in drug preparation. His contributions are expected to have a lasting impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
